Categories: News

Flexsys Announces Price Increase for Insoluble Sulfur in Asia

AKRON, Ohio, June 18, 2026 /PRNewswire/ — Effective on or after June 18, 2026, or as contracts allow, Flexsys is announcing a price increase in Asia for the following products, in the following territories:

- Advertisement -
  • Insoluble Sulfur, all grades and pack types, in China: +US$ 0.60/kg
  • Insoluble Sulfur, all grades and pack types, in India: +US$ 0.25/kg
  • Insoluble Sulfur, all grades and pack types, in the rest of Asia: +US$ 0.60/kg

About Flexsys

- Advertisement -

Flexsys is a global specialty chemicals and materials technology company that innovates and produces a range of tire additives with the purpose of enabling tire companies to improve tire performance and manufacturing productivity, while enhancing sustainability through innovation. Based in Akron, Ohio, with manufacturing facilities across North America, South America, Europe and Asia, our global team is committed to the success of our customers.

- Advertisement -

For additional information about Flexsys, please visit www.flexsys.com

- Advertisement -

Recent Posts

Both Leading Independent Proxy Advisors Recommend Aterian Stockholders Vote for the Asset Sale

July 08, 2026 17:30 ET  | Source: Aterian, Inc Glass Lewis cites structured strategic reviewISS…

3 hours ago

Republic Power Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

July 08, 2026 16:30 ET  | Source: Republic Power Group Limited Singapore, July 08, 2026…

3 hours ago

Groove Technology Solutions Partners with HPS to Expand Access to Property Technology Solutions

July 08, 2026 16:29 ET  | Source: Groove Technology Solutions Salt Lake City, July 08,…

3 hours ago

Outliyr’s Independent Spectrometer Tests Find Popular Red Light Therapy Devices Delivering From 67 Percent to Nearly Triple Their Advertised Power

Outliyr's free public database catalogs more than seventy red light therapy panels and other light…

3 hours ago

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage…

3 hours ago

Range Impact Announces Vin Ferrara, MD, MBA, Has Joined the Company as Vice President, Real Estate

CLEVELAND, OHIO, July 08, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact”…

3 hours ago